Analysis of Surface Levels of IL-1 Receptors and Macrophage Scavenger Receptor I in Peripheral Immune Cells of Patients With Alzheimer Disease.
Alzheimer disease
IL-1RI
MSRI
biomarker
dementia
neurodegeneration
neuroinflammation
Journal
Journal of geriatric psychiatry and neurology
ISSN: 0891-9887
Titre abrégé: J Geriatr Psychiatry Neurol
Pays: United States
ID NLM: 8805645
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
pubmed:
26
4
2019
medline:
15
4
2020
entrez:
26
4
2019
Statut:
ppublish
Résumé
Increased concentrations of interleukin 1 (IL-1) in the cerebrospinal fluid and serum of patients with Alzheimer disease (AD) reduced phagocytic capacity point to an inflammatory activation of mononuclear phagocytes in AD. Interleukin 1 receptors (IL-1R) and the macrophage scavenger receptor I (MSRI) are important players in IL-1 signaling and phagocytosis. In 20 patients with AD and 17 controls, IL-1RI, IL-1RII, and MSRI were assessed on peripheral blood mononuclear cells by flow cytometry. IL-1β, soluble IL-1 receptors, and IL-1R antagonist (IL-1Ra) were measured by enzyme-linked immunosorbent assay. The fraction of IL-1RI+ monocytes was increased by 10% and the expression of MSRI was reduced by 12% in AD. A 3.6% increased fraction of IL-1RI+ lymphocytes was accompanied by a 6.1% reduced expression of IL-1RII. The IL-1RI on monocytes and lymphocytes discriminated patients with AD with an accuracy of 0.79 and 0.75, respectively. The IL-1Ra was elevated in AD. Changes in the expression of IL-1 receptors and MSRI on peripheral blood cells fit to the concept of a proinflammatory state of the peripheral immune system. However, the observed differences are not strong enough to suggest their application as biomarkers for AD.
Identifiants
pubmed: 31018751
doi: 10.1177/0891988719841728
pmc: PMC6552296
doi:
Substances chimiques
Receptors, Interleukin-1
0
Receptors, Scavenger
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
211-220Références
Life Sci. 1999;65(5):449-81
pubmed: 10462074
J Neurosci Res. 2004 Oct 15;78(2):151-6
pubmed: 15378607
Trends Immunol. 2004 Dec;25(12):677-86
pubmed: 15530839
J Neuroinflammation. 2005 Mar 11;2(1):9
pubmed: 15762998
J Alzheimers Dis. 2005 Jun;7(3):221-32; discussion 255-62
pubmed: 16006665
Neuron. 2006 Feb 16;49(4):489-502
pubmed: 16476660
Ann N Y Acad Sci. 2007 Oct;1113:173-7
pubmed: 17656565
Int Rev Neurobiol. 2007;82:205-33
pubmed: 17678963
Neurobiol Aging. 2010 Jan;31(1):17-24
pubmed: 18455839
J Neurol Sci. 2008 Sep 15;272(1-2):164-70
pubmed: 18597785
J Neurosci. 2008 Aug 13;28(33):8354-60
pubmed: 18701698
Immunol Rev. 2008 Dec;226:10-8
pubmed: 19161412
Brain Behav Immun. 2009 Jul;23(5):573-9
pubmed: 19258032
Nat Immunol. 2010 Feb;11(2):155-61
pubmed: 20037584
Biol Psychiatry. 2010 Nov 15;68(10):930-41
pubmed: 20692646
J Immunol. 2011 Dec 15;187(12):6539-49
pubmed: 22095718
Arch Neurol. 2012 Jul;69(7):824-31
pubmed: 22451159
J Clin Invest. 2012 Apr;122(4):1156-63
pubmed: 22466657
J Neuroimmunol. 2012 Oct 15;251(1-2):6-13
pubmed: 22743055
Cytotechnology. 2013 Oct;65(5):795-802
pubmed: 23440375
Nat Commun. 2013;4:2030
pubmed: 23799536
PLoS One. 2013 Sep 20;8(9):e75091
pubmed: 24073237
Semin Immunol. 2013 Dec 15;25(6):394-407
pubmed: 24246227
Immunity. 2013 Dec 12;39(6):1003-18
pubmed: 24332029
Clin Biochem. 2014 Mar;47(4-5):288-92
pubmed: 24389077
Mol Neurobiol. 2014 Oct;50(2):534-44
pubmed: 24567119
Lancet Neurol. 2014 Jun;13(6):614-29
pubmed: 24849862
Proc Natl Acad Sci U S A. 1989 Oct;86(19):7606-10
pubmed: 2508093
Lancet Neurol. 2015 Apr;14(4):388-405
pubmed: 25792098
Nat Rev Neurosci. 2015 Jun;16(6):358-72
pubmed: 25991443
Proc Natl Acad Sci U S A. 2015 Sep 8;112(36):E5078-87
pubmed: 26305968
Biomark Med. 2016;10(1):1-4
pubmed: 26640978
Neurology. 2016 Aug 2;87(5):539-47
pubmed: 27371494
Aging Cell. 2017 Feb;16(1):27-38
pubmed: 27723233
J Immunol Res. 2017;2017:4626540
pubmed: 28293644
Psychopharmacol Bull. 1988;24(4):641-52
pubmed: 3249766
Nature. 1996 Aug 22;382(6593):716-9
pubmed: 8751442